MedAmicus' LuMax Uroflow system introduced:
This article was originally published in Clinica
Minnesota-based MedAmicus (US) has introduced its LuMax Uroflow system and other enhancements for the LuMax fibre optic cystometry system. The Uroflow allows uroflow and pressure flow studies to determine appropriate therapies for male patients with obstructed voiding due to benign prostatic hyperplasia. Other enhancements introduced at the AUA include reusable fibre optic catheters and a volume infused transducer for marking infused volume of saline at key diagnostic events.
You may also be interested in...
Roughly 18.5% of patients who received reinterventions to fix mesh implants for pelvic organ prolapse (POP) repair experienced complications they will likely endure for the rest of their lives, and they also face a 2.5% higher rate of further surgeries than non-mesh patients, says a recent 54,194-woman study detailed in Obstetrics & Gynecology. The study authors lay out a case that the US FDA should have forced removal of mesh from the market sooner.
HAL Allergy Group, developer of products for allergy diagnostics and allergen immunotherapy, promoted its principal scientist to chief R&D officer; Starkey Hearing Technologies brought on new health and business development execs to expand its global footprint; and more.